I. King
Impact in
- Biotechnology top 1%
- Cancer Research and Treatments
-
- S100 Proteins and Annexins
- RNA Interference and Gene Delivery
- Retinoids in leukemia and cellular processes
Papers in
-
- Cancer Research and Treatments 3
-
- Pharmacogenetics and Drug Metabolism 2
- Microbial Natural Products and Biosynthesis 1
- Co-authors
- Alan C. Sartorelli (3 shared papers)Lan Zheng (4 shared papers)David G. Bermudes (3 shared papers)Stephen M. Brecher (1 shared paper)John M. Pawelek (1 shared paper)Caroline Clairmont (2 shared papers)K. Brooks Low (1 shared paper)Martina Ittensohn (2 shared papers)
- Journals
- Journal of Cellular Physiology (1 paper)Journal of Clinical Investigation (1 paper)Journal of Controlled Release (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
I. King
12 papers receiving 569 citations
Peers
Comparison fields: 5 of 55
- Biotechnology 300
- Molecular Biology 140
- Epidemiology 41
- Hematology 15
- Otorhinolaryngology 6
Countries citing papers authored by I. King
This map shows the geographic impact of I. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. King more than expected).
Fields of papers citing papers by I. King
This network shows the impact of papers produced by I. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. King. The network helps show where I. King may publish in the future.
Co-authors
The 25 scholars most cited alongside I. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 315 | |
| 2 | 1990 | 92 | |
| 3 | 2001 | 55 | |
| 4 | 2001 | 37 | |
| 5 | Differentiation of WEHI-3B D+ myelomonocytic leukemia cells induced by ectopic expression of the protooncogene c-jun. | 1994 | 27 |
| 6 | Epidermal growth factor receptor gene expression, protein kinase activity, and terminal differentiation of human malignant epidermal cells. | 1989 | 24 |
| 7 | Interaction of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with human immunodeficiency virus-1 reverse transcriptase and human DNA polymerases: implications for human immunodeficiency virus drug design. | 1998 | 14 |
| 8 | 1998 | 11 | |
| 9 | 2000 | 4 | |
| 10 | 2011 | 3 | |
| 11 | Antitumor effect of keto-diepoxides isolated from the fungus Nattrassia mangiferae. | 1995 | 2 |
| 12 | 2010 | 2 | |
| 13 | 2025 | 1 |
About I. King
I. King is a scholar working on Biotechnology, Pharmacology, Pharmacology, Hematology and Infectious Diseases, having authored 13 papers that have together received 587 indexed citations. Recurring topics across this work include Cancer Research and Treatments (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Microbial Natural Products and Biosynthesis (1 paper), Acute Myeloid Leukemia Research (1 paper), Hepatitis B Virus Studies (1 paper), S100 Proteins and Annexins (1 paper), Prostate Cancer Treatment and Research (1 paper) and HIV/AIDS drug development and treatment (1 paper). The work is most often cited by research in Biotechnology (300 citations), Molecular Biology (140 citations), Epidemiology (41 citations), Hematology (15 citations) and Otorhinolaryngology (6 citations). I. King has collaborated with scholars based in United States and France. Frequent co-authors include Alan C. Sartorelli, Lan Zheng, David G. Bermudes, Stephen M. Brecher, John M. Pawelek, Caroline Clairmont, K. Brooks Low, Martina Ittensohn, Shelia M. Violette and Jeffrey L. Browning. Their work appears in journals such as Journal of Cellular Physiology, Journal of Clinical Investigation, Journal of Controlled Release, Antimicrobial Agents and Chemotherapy and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.